Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells

Molecular and Cellular Biology

Volumn 25, Issue 18, 2005, Pages 8037-8043

  Takakura, Masahiro ^a,b   Kyo, Satoru ^b   Inoue, Masaki ^b   Wright, Woodring E ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN C FOS; PROTEIN C JUN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FIBROBLAST; GENE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE STRUCTURE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SPECIES DIFFERENCE; TERT GENE; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NIH 3T3 CELLS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TELOMERASE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 24344466208     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.18.8037-8043.2005     Document Type: Article

References (44)

1. 2 kinase (JNK) contributes to the regulation of c-Myc protein stability. J. Biol. Chem. 279:5008-5016.
2. 2-terminal kinase in ovarian surface epithelial cells. Cancer Res. 62:4575-4578.
3. Ameyar, M., M. Wisniewska, and J. B. Weitzman. 2003. A role for AP-1 in apoptosis: the case for and against. Biochimie 85:747-752.
4. Arias, J., A. S. Alberts, P. Brindle, F. X. Claret, T. Smeal, M. Karin, J. Feramisco, and M. Montminy. 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370:226-229.
5. Autexier, C., R. Pruzan, W. D. Funk, and C. W. Greider. 1996. Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. EMBO J. 15:5928-5935.
6. Bodnar, A. G., M. Ouellette, M. Frolkis, S. E. Holt, C. P. Chiu, G. B. Morin, C. B. Barley, J. W. Shay, S. Lichtsteiner, and W. E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
7. Bushel, P., J. H. Kim, W. Chang, J. J. Catino, H. E. Ruley, and C. C. Kurnar. 1995. Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells. Oncogene 10:1361-1370.
8. Cong, Y. S., J. Wen, and S. Bacchetti. 1999. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet. 8:137-142.
9. Counter, C. M., J. Gupta, C. B. Harley, B. Leber, and S. Bacchetti. 1995. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315-2320.
10. Devereux, T. R., I. Horikawa, C. H. Anna, L. A. Annab, C. A. Afshari, and J. C. Barrett. 1999. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res. 59:6087-6090.
11. Feng, J., W. D. Funk, S. S. Wang, S. L. Weinrich, A. A. Avilion, C. P. Chin, R. R. Adams, E. Chang, R. C. Allsopp, J. Yu, et al. 1995. The RNA component of human telomerase. Science 269:1236-1241.
12. Greenberg, R. A., R. C. Allsopp, L. Chin, G. B. Morin, and R. A. DePinho. 1998. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16:1723-1730.
13. Harle-Bachor, C., and P. Boukamp. 1996. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93:6476-6481.
14. Harley, C. B., A. B. Futcher, and C. W. Greider. 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460.
15. Hirai, S., B. Bourachot, and M. Yaniv. 1990. Both Jun and Fos contribute to transcription activation by the heterodimer. Oncogene 5:39-46.
16. Hiyama, K., Y. Hirai, S. Kyoizumi, M. Akiyama, E. Hiyama, M. A. Piatyszek, J. W. Shay, S. Ishioka, and M. Yamakido. 1995. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711-3715.
17. Horikawa, I., P. L. Cable, C. Afshari, and J. C. Barrett. 1999. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59:826-830.
18. Iavarone, C., A. Catania, M. J. Marinissen, R. Visconti, M. Acunzo, C. Tarantino, M. S. Carlomagno, C. B. Bruni, J. S. Gutkind, and M. Chiariello. 2003. The platelet-derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway. J. Biol. Chem. 278:50024-50030.
19. Ito, H., S. Kyo, T. Kanaya, M. Takakura, M. Inoue, and M. Namiki. 1998. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin. Cancer Res. 4:1603-1608.
20. Kanaya, T., S. Kyo, M. Takakura, H. Ito, M. Namiki, and M. Inoue. 1998. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int. J. Cancer 78:539-543.
21. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich, and J. W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
22. Kugoh, H., K. Shigenami, K. Funaki, J. C. Barrett, and M. Oshimura. 2003. Human chromosome 5 carries a putative telomerase repressor gene. Genes Chromosomes Cancer 36:37-47.
23. Kyo, S., and M. Inoue. 2002. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene 21:688-697.
24. Kyo, S., T. Kanaya, M. Takakura, M. Tanaka, and M. Inoue. 1999. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int. J. Cancer 80:60-63.
25. Kyo, S., M. Takakura, T. Kohama, and M. Inoue. 1997. Telomerase activity in human endometrium. Cancer Res. 57:610-614.
26. Kyo, S., M. Takakura, T. Taira, T. Kanaya, H. Itoh, M. Yutsudo, H. Ariga, and M. Inoue. 2000. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 28:669-677.
27. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
28. Meyerson, M., C. M. Counter, E. N. Eaton, L. W. Ellisen, P. Steiner, S. D. Caddie, L. Ziaugra, R. L. Beijersbergen, M. J. Davidoff, Q. Liu, S. Bacchedi, D. A. Haber, and R. A. Weinberg. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795.
29. Nakamura, T. M., G. B. Morin, K. B. Chapman, S. L. Weinrich, W. H. Andrews, J. Lingner, C. B. Harley, and T. R. Cech. 1997. Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959.
30. Nakayama, J., H. Tahara, E. Tahara, M. Saito, K. Ito, H. Nakamura, T. Nakanishi, E. Tahara, T. Ide, and F. Ishikawa. 1998. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18:65-68.
31. Nishimoto, A., N. Miura, I. Horikawa, H. Kugoh, Y. Murakami, S. Hirohashi, H. Kawasaki, A. F. Gazdar, J. W. Shay, J. C. Barrett, and M. Oshimura. 2001. Functional evidence for a telomerase repressor gene on human chromosome 10p15.1. Oncogene 20:828-835.
32. Nozawa, K., K. Maehara, and K. Isobe. 2001. Mechanism for the reduction of telomerase expression during muscle cell differentiation. J. Biol. Chem. 276:22016-22023.
33. Ohno, J., Y. Horio, Y. Sekido, Y. Hasegawa, M. Takahashi, J. Nishizawa, H. Saito, F. Ishikawa, and K. Shimokata. 2001. Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development. Carcinogenesis 22:751-756.
34. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
35. Schreiber, M., A. Kolbus, F. Piu, A. Szabowski, U. Mohle-Steinlein, J. Tian, M. Karin, P. Angel, and E. F. Wagner. 1999. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13:607-619.
36. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:E131-E136.
37. Shay, J. W., and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer 33:787-791.
38. Takakura, M., S. Kyo, T. Kanaya, H. Hirano, J. Takeda, M. Yutsudo, and M. Inoue. 1999. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59:551-557.
39. Takakura, M., S. Kyo, T. Kanaya, M. Tanaka, and M. Inoue. 1998. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 58:1558-1561.
40. Takakura, M., S. Kyo, Y. Sowa, Z. Wang, N. Yatabe, Y. Maida, M. Tanaka, and M. Inoue. 2001. Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res. 29:3006-3011.
41. Tanaka, H., M. Shimizu, I. Horikawa, H. Kugoh, J. Yokota, J. C. Barrett, and M. Oshimura. 1998. Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region. Genes Chromosomes Cancer 23:123-133.
42. Vaziri, H., W. Dragowska, R. C. Allsopp, T. E. Thomas, C. B. Harley, and P. M. Lansdorp. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91:9857-9860.
43. Yasumoto, S., C. Kunimura, K. Kikuchi, H. Tahara, H. Ohji, H. Yamamoto, T. Ide, and T. Utakoji. 1996. Telomerase activity in normal human epithelial cells. Oncogene 13:433-439.
44. Yi, X., J. W. Shay, and W. E. Wright. 2001. Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res. 29:4818-4825.